Eli Lilly to Sell Half-Price Insulin

March 5, 2019

Drug manufacturer Eli Lilly says it will introduce an authorized generic version of Humalog, one of its most popular insulins. At $137.35 per vial, Insulin Lispro will be sold for 50 percent of the brand name price. It will be sold through a Lilly subsidiary called ImClone Systems, and the company says it will be available “as quickly as possible.”

Lilly will continue selling Humalog at its regular price, preserving rebates and other incentives in place with PBMs and insurers for the brand name insulin. The generic is most likely to benefit patients paying for insulin out of pocket.

Insulin—which type 1 diabetic patients need to live—has been around since the 1920s. Manufacturers like Lilly, Novo Nordisk, and Sanofi, have raised prices from about $20 per vial in 1996 to about $275 per vial today, prompting lawmakers and advocates to demand action.

Read the New York Times story.